Given the important roles of CD200-CD200R interaction in regulating tumor associated myeloid cells and in inhibiting tumor formation and metastasis, targeting CD200-CD200R interaction should provide an option for the immunotherapy of human cancer. The gene discussed is CD200R1; the disease is neoplasm.